Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: A randomized, double-masked, crossover study

Published:January 12, 2011DOI:https://doi.org/10.1016/j.clnu.2011.01.001

      Summary

      Background & aims

      Metabolic effects of dietary fat quality in people with type 2 diabetes are not well-understood. The study objective was to evaluate effects of conjugated linoleic acid (CLA) and safflower (SAF) oils on glycemia, blood lipids, and inflammation. The hypothesis we tested is that dietary oils improve glycemia, lipids, and inflammatory markers in a time-dependent way that follows accumulation of linoleic acid and CLA isomers in serum of subjects supplemented with dietary oils.

      Methods

      Fifty-five post-menopausal, obese women with type 2 diabetes enrolled, and 35 completed this randomized, double-masked crossover study. Treatments were 8 g daily of CLA and SAF for 16 weeks each. We used a multiple testing procedure with pre-determined steps analysis to determine the earliest time that a significant effect was detected.

      Results

      CLA did not alter measured metabolic parameters. SAF decreased HbA1c (−0.64 ± 0.18%, p = 0.0007) and C-reactive protein (−13.6 ± 8.2 mg/L, p = 0.0472), increased QUICKI (0.0077 ± 0.0035, p = 0.0146) with a minimum time to effect observed 16 weeks after treatment. SAF increased HDL cholesterol (0.12 ± 0.05 mmol/L, p = 0.0228) with the minimum time to detect an effect of SAF at 12 weeks. The minimum time to detect an increase of c9t11-CLA, t10c12-CLA, and linoleic acid in serum of women supplemented CLA or SAF, respectively, was four weeks.

      Conclusions

      We conclude that 8 g of SAF daily improved glycemia, inflammation, and blood lipids, indicating that small changes in dietary fat quality may augment diabetes treatments to improve risk factors for diabetes-related complications.

      Keywords

      Abbreviations:

      CLA (conjugated linoleic acid), SAF (safflower oil)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Caterson I.D.
        • Hubbard V.
        • Bray G.A.
        • Grunstein R.
        • Hansen B.C.
        • Hong Y.
        • et al.
        Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: group III: worldwide comorbidities of obesity.
        Circulation. 2004; 110: e476-e483
        • Bantle J.P.
        • Wylie-Rosett J.
        • Albright A.L.
        • Apovian C.M.
        • Clark N.G.
        • Franz M.J.
        • et al.
        Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association.
        Diabetes Care. 2008; 1: S61-S78
        • Fox C.S.
        • Massaro J.M.
        • Hoffmann U.
        • Pou K.M.
        • Maurovich-Horvat P.
        • Liu C.Y.
        • et al.
        Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.
        Circulation. 2007; 116: 39-48
        • Klein S.
        • Sheard N.F.
        • Pi-Sunyer X.
        • Daly A.
        • Wylie-Rosett J.
        • Kulkarni K.
        • et al.
        Weight management through lifestyle modification for the prevention and management of type 2 Diabetes: rationale and strategies: a statement of the American diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition.
        Diabetes Care. 2004; 27: 2067-2073
        • Ray K.K.
        • Seshasai S.R.
        • Wijesuriya S.
        • Sivakumaran R.
        • Nethercott S.
        • Preiss D.
        • et al.
        Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
        Lancet. 2009; 373: 1765-1772
        • Wing R.R.
        • Phelan S.
        Long-term weight loss maintenance.
        Am J Clin Nutr. 2005; 82: 222S-225S
        • Pillitteri J.L.
        • Shiffman S.
        • Rohay J.M.
        • Harkins A.M.
        • Burton S.L.
        • Wadden T.A.
        Use of dietary supplements for weight loss in the United States: results of a national survey.
        Obes (Silver Spring). 2008; 16: 790-796
        • Belury M.A.
        Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action.
        Annu Rev Nutr. 2002; 22: 505-531
        • Whigham L.D.
        • Watras A.C.
        • Schoeller D.A.
        Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans.
        Am J Clin Nutr. 2007; 85: 1203-1211
        • Norris L.E.
        • Collene A.L.
        • Asp M.L.
        • Hsu J.C.
        • Liu L.F.
        • Richardson J.R.
        • et al.
        Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus.
        Am J Clin Nutr. 2009; 90: 468-476
        • Harris W.S.
        • Mozaffarian D.
        • Rimm E.
        • Kris-Etherton P.
        • Rudel L.L.
        • Appel L.J.
        • et al.
        Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention.
        Circulation. 2009; 119: 902-907
        • Moshfegh A.
        • Goldman J.
        • Cleveland L.
        What we eat in America, NHANES 2001-2002: Usual nutrient intakes from food compared to dietary reference intakes.
        U.S Department Agriculture Agric Res Serv. 2005;
        • Wolever T.M.
        • Jenkins D.J.
        • Jenkins A.L.
        • Josse R.G.
        The glycemic index: methodology and clinical implications.
        Am J Clin Nutr. 1991; 54: 846-854
        • Katz A.
        • Nambi S.S.
        • Mather K.
        • Baron A.D.
        • Follmann D.A.
        • Sullivan G.
        • et al.
        Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.
        J Clin Endocrinol Metab. 2000; 85: 2402-2410
        • Belury M.A.
        • Kempa-Steczko A.
        Conjugated linoleic acid modulates hepatic lipid composition in mice.
        Lipids. 1997; 32: 199-204
        • Hsu J.C.
        • Berger R.L.
        Stepwise confidence intervals without multiplicity adjustment for dose-response and toxicity studies.
        J Am Stat Assoc. 1999; 94: 468-482
        • Moloney F.
        • Yeow T.P.
        • Mullen A.
        • Nolan J.J.
        • Roche H.M.
        Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.
        Am J Clin Nutr. 2004; 80: 887-895
        • Preis S.R.
        • Massaro J.M.
        • Robins S.J.
        • Hoffmann U.
        • Vasan R.S.
        • Irlbeck T.
        • et al.
        Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study.
        Obesity. 2010; 18: 2191-2198
        • Lemieux I.
        • Pascot A.
        • Prud’homme D.
        • Alméras N.
        • Bogaty P.
        • Nadeau A.
        • et al.
        Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity.
        Arterioscler Thromb Vasc Biol. 2001; 21: 961-967
        • Jain S.H.
        • Massaro J.M.
        • Hoffmann U.
        • Rosito G.A.
        • Vasan R.S.
        • Raji A.
        • O’Donnell C.J.
        • et al.
        Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study.
        Diabetes Care. 2009; 32: 903-908
        • Porter S.A.
        • Massaro J.M.
        • Hoffmann U.
        • Vasan R.S.
        • O’Donnel C.J.
        • Fox C.S.
        Abdominal subcutaneous adipose tissue: a protective fat depot?.
        Diabetes Care. 2009; 32: 1068-1075
        • Kannel W.B.
        Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.
        Am Heart J. 1987; 114: 413-419
        • Gordon D.J.
        • Probstfield J.L.
        • Garrison R.J.
        • Neaton J.D.
        • Castelli W.P.
        • Knoke J.D.
        • et al.
        High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
        Circulation. 1989; 79: 8-15
        • Ridker P.M.
        • Hennekens C.H.
        • Buring J.E.
        • Rifai N.
        C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
        New Engl J Med. 2000; 342: 836-843